Pharmacokinetic/pharmacodynamic-based decision making in the development of MK-0888, a VEGFR-2/FLT-3 kinase inhibitor
Crossref DOI link: https://doi.org/10.1007/s00280-014-2649-8
Published Online: 2014-12-19
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Iwamoto, Marian
Friedman, Evan J.
Sepp-Lorenzino, Laura
Talaty, Jennifer E.
Agrawal, Nancy G. B.
Wagner, John A.
Text and Data Mining valid from 2014-12-19